• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促炎细胞因子、脂肪因子和氧化应激与胰岛素抵抗和非酒精性脂肪性肝病的关系。

Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease.

机构信息

Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Indian J Med Res. 2012 Aug;136(2):229-36.

PMID:22960889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3461734/
Abstract

BACKGROUND & OBJECTIVES: The cytokines, adipokines, and oxidative stress have been implicated in the pathogenesis of non-alcoholic fatty liver disease (NAFLD); however, such data remain scarce in India. The present study evaluated pro-inflammatory cytokines, adipokines, and markers of oxidative stress in patients with non-alcoholic fatty liver disease (NAFLD), and their association with degree of adiposity, insulin resistance and markers of disease severity.

METHODS

The present prospective cross-sectional pilot study included 79 subjects; 34 NAFLD, 22 chronic hepatitis B (CH-B) and 23 healthy controls (HC). The parameters studied were adiponectin, leptin, tumour necrosis factor α (TNFα), interleukin-1 and 6 (IL-1, IL-6), and systemic markers of oxidative stress.

RESULTS

The mean body mass index (kg/m 2 ) in NAFLD patients, CHB, and HC were 26.4±3.7, 21.3±2.3, and 22.3±2.7, respectively. The median serum levels of all pro-inflammatory cytokines were significantly higher (P<0.001) in NAFLD compared to control groups. Compared to HC, levels of adiponectin and leptin were significantly (P<0.05, P<0.01) reduced in both NAFLD and CHB. IL-6 showed marked and selective increase only in NAFLD patients. The levels of IL-6 were significantly (P<0.02) higher in NAFLD patients with advanced histology grade and correlated with IR (r=0.42, P=0.02). In a sub-group, markers of oxidative stress were significantly higher, and that of antioxidant potential were significantly lower among NAFLD patients compared to control subjects.

INTERPRETATION & CONCLUSIONS: Patients with NAFLD revealed significantly elevated levels of pro-inflammatory cytokines, increased oxidative stress, and a significant association of IL-6 with IR and advanced histopathology.

摘要

背景与目的

细胞因子、脂肪因子和氧化应激与非酒精性脂肪性肝病(NAFLD)的发病机制有关;然而,在印度,此类数据仍然很少。本研究评估了非酒精性脂肪性肝病(NAFLD)患者的促炎细胞因子、脂肪因子和氧化应激标志物,并研究了它们与肥胖程度、胰岛素抵抗和疾病严重程度标志物的关系。

方法

本前瞻性横断面研究纳入了 79 名受试者;34 名 NAFLD 患者、22 名慢性乙型肝炎(CH-B)患者和 23 名健康对照者(HC)。研究的参数包括脂联素、瘦素、肿瘤坏死因子-α(TNF-α)、白细胞介素-1 和 6(IL-1、IL-6)以及系统性氧化应激标志物。

结果

NAFLD 患者、CHB 患者和 HC 的平均体重指数(kg/m 2 )分别为 26.4±3.7、21.3±2.3 和 22.3±2.7。与对照组相比,NAFLD 患者所有促炎细胞因子的中位数血清水平均显著升高(P<0.001)。与 HC 相比,NAFLD 和 CHB 患者的脂联素和瘦素水平均显著降低(P<0.05,P<0.01)。只有在 NAFLD 患者中,IL-6 显示出明显且选择性的增加。IL-6 水平在具有晚期组织学分级的 NAFLD 患者中显著升高(P<0.02),并与 IR 相关(r=0.42,P=0.02)。在一个亚组中,与对照组相比,NAFLD 患者的氧化应激标志物显著升高,抗氧化潜力标志物显著降低。

解释与结论

NAFLD 患者表现出明显升高的促炎细胞因子水平、氧化应激增加,并且 IL-6 与 IR 和晚期组织病理学显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8979/3461734/72dd0c5e15fd/IJMR-136-229-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8979/3461734/0035467ef3ba/IJMR-136-229-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8979/3461734/72dd0c5e15fd/IJMR-136-229-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8979/3461734/0035467ef3ba/IJMR-136-229-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8979/3461734/72dd0c5e15fd/IJMR-136-229-g005.jpg

相似文献

1
Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease.促炎细胞因子、脂肪因子和氧化应激与胰岛素抵抗和非酒精性脂肪性肝病的关系。
Indian J Med Res. 2012 Aug;136(2):229-36.
2
Adipokines and cytokines in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的脂肪因子和细胞因子
Aliment Pharmacol Ther. 2008 Mar 1;27(5):412-21. doi: 10.1111/j.1365-2036.2007.03586.x. Epub 2007 Dec 10.
3
Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患儿骨钙素和护骨素水平及其与脂肪因子和促炎细胞因子的关系。
Cytokine. 2020 Nov;135:155215. doi: 10.1016/j.cyto.2020.155215. Epub 2020 Jul 27.
4
Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease.氧化应激和胰岛素抵抗在非酒精性脂肪性肝病疾病严重程度中的作用。
Turk J Gastroenterol. 2016 Jul;27(4):361-6. doi: 10.5152/tjg.2016.16106.
5
Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake.亚硝化应激可预测胰岛素抵抗和代谢综合征不同发展阶段非酒精性脂肪肝的存在及严重程度:维生素A摄入的可能作用。
Am J Clin Nutr. 2007 Sep;86(3):661-71. doi: 10.1093/ajcn/86.3.661.
6
Irisin in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的鸢尾素。
Metabolism. 2014 Feb;63(2):207-17. doi: 10.1016/j.metabol.2013.09.013. Epub 2013 Oct 18.
7
Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.血浆内脂素与非酒精性脂肪性肝病的肝及全身炎症的相关性。
Ann Hepatol. 2013 Jul-Aug;12(4):548-55.
8
CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS.病态肥胖个体中非酒精性脂肪性肝病特征与脂肪因子和炎性细胞因子水平的相关性
Arq Gastroenterol. 2018 Jul-Sep;55(3):247-251. doi: 10.1590/S0004-2803.201800000-62.
9
Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease.规律运动与饮食方案相结合可加速非酒精性脂肪性肝病患者肝脂肪变性及相关病理状况的减轻。
Metab Syndr Relat Disord. 2014 Jun;12(5):290-8. doi: 10.1089/met.2013.0143. Epub 2014 Apr 1.
10
Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)患者的氧化应激与抗氧化状态
J Clin Gastroenterol. 2006 Nov-Dec;40(10):930-5. doi: 10.1097/01.mcg.0000212608.59090.08.

引用本文的文献

1
Role of prokineticins and T-reg cells in obesity-associated metabolic oxidative dysregulation in NAFLD.前动力蛋白和调节性T细胞在非酒精性脂肪性肝病中肥胖相关代谢性氧化失调中的作用。
Sci Rep. 2025 Aug 12;15(1):29470. doi: 10.1038/s41598-025-97969-2.
2
Obesity-Associated NAFLD Coexists with a Chronic Inflammatory Kidney Condition That Is Partially Mitigated by Short-Term Oral Metformin.肥胖相关的非酒精性脂肪性肝病与一种慢性炎症性肾脏疾病共存,短期口服二甲双胍可部分缓解该肾脏疾病。
Nutrients. 2025 Jun 26;17(13):2115. doi: 10.3390/nu17132115.
3
Protective effects of shikimic acid against thioacetamide-induced hepatic fibrosis: role of Nrf2/NF-κB signaling pathways.

本文引用的文献

1
Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.发展中国家的非肥胖人群中非酒精性脂肪肝和显著肝脏疾病的患病率很高。
Hepatology. 2010 May;51(5):1593-602. doi: 10.1002/hep.23567.
2
Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.慢性肝病患者血清脂肪因子水平:抵抗素水平与肝纤维化严重程度的关联
Scand J Gastroenterol. 2008;43(9):1128-36. doi: 10.1080/00365520802085387.
3
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
莽草酸对硫代乙酰胺诱导的肝纤维化的保护作用:Nrf2/NF-κB信号通路的作用
Front Pharmacol. 2025 May 30;16:1609711. doi: 10.3389/fphar.2025.1609711. eCollection 2025.
4
Extracellular vesicles in Helicobacter pylori-mediated diseases: mechanisms and therapeutic potential.幽门螺杆菌介导的疾病中的细胞外囊泡:机制与治疗潜力
Cell Commun Signal. 2025 Feb 11;23(1):79. doi: 10.1186/s12964-025-02074-6.
5
Carotid Intima-Media Thickness in Indian Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and a Meta-Analysis.印度非酒精性脂肪性肝病患者的颈动脉内膜中层厚度:一项系统评价和荟萃分析。
Cureus. 2024 Sep 2;16(9):e68439. doi: 10.7759/cureus.68439. eCollection 2024 Sep.
6
Inflammatory Protein Signatures as Predictive Disease-Specific Markers for Non-Alcoholic Steatohepatitis (NASH).炎症蛋白特征作为非酒精性脂肪性肝炎(NASH)的疾病特异性预测标志物
Inflammation. 2025 Feb;48(1):25-41. doi: 10.1007/s10753-024-02035-0. Epub 2024 Apr 27.
7
Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus.中国 2 型糖尿病患者中非酒精性脂肪性肝病和肝硬化的患病率。
J Diabetes. 2024 May;16(5):e13564. doi: 10.1111/1753-0407.13564.
8
Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review.解析胰岛素抵抗与非酒精性脂肪性肝病(或代谢功能障碍相关脂肪性肝病)之间的联系:一篇叙述性综述
J Diabetes Metab Disord. 2023 Sep 8;22(2):1083-1094. doi: 10.1007/s40200-023-01293-3. eCollection 2023 Dec.
9
Integrated bioinformatics analysis reveals potential mechanisms associated with intestinal flora intervention in nonalcoholic fatty liver disease.整合生物信息学分析揭示了肠道菌群干预非酒精性脂肪性肝病的潜在机制。
Medicine (Baltimore). 2022 Sep 9;101(36):e30184. doi: 10.1097/MD.0000000000030184.
10
Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.肝移植患者非酒精性脂肪性肝病发生过程中的肝外器官
Hepatobiliary Surg Nutr. 2022 Jun;11(3):400-411. doi: 10.21037/hbsn-20-568.
人类非酒精性脂肪性肝炎中肝脏和循环中白细胞介素-6水平升高。
Am J Gastroenterol. 2008 Jun;103(6):1372-9. doi: 10.1111/j.1572-0241.2007.01774.x. Epub 2008 May 28.
4
Adipokines and cytokines in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的脂肪因子和细胞因子
Aliment Pharmacol Ther. 2008 Mar 1;27(5):412-21. doi: 10.1111/j.1365-2036.2007.03586.x. Epub 2007 Dec 10.
5
Macrophage-adipocyte interaction: marked interleukin-6 production by lipopolysaccharide.巨噬细胞-脂肪细胞相互作用:脂多糖显著诱导白细胞介素-6生成。
Obesity (Silver Spring). 2007 Nov;15(11):2549-52. doi: 10.1038/oby.2007.305.
6
How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?非酒精性脂肪性肝病在亚太地区的发病率如何,是否存在地区差异?
J Gastroenterol Hepatol. 2007 Jun;22(6):788-93. doi: 10.1111/j.1440-1746.2007.05042.x.
7
The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West.印度非酒精性脂肪性肝病(NAFLD)患者的临床病理特征与西方患者不同。
Dig Dis Sci. 2007 Sep;52(9):2368-74. doi: 10.1007/s10620-006-9136-y. Epub 2007 Apr 10.
8
Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.亚洲印度男性中胰岛素抵抗和非酒精性脂肪性肝病的患病率增加。
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18273-7. doi: 10.1073/pnas.0608537103. Epub 2006 Nov 17.
9
Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians.在亚洲印度人群中,非酒精性脂肪性肝病在发病时可能并非严重疾病。
World J Gastroenterol. 2006 Jun 7;12(21):3400-5. doi: 10.3748/wjg.v12.i21.3400.
10
Pathophysiology of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的病理生理学
J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S17-29. doi: 10.1097/01.mcg.0000168645.86658.22.